We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · November 22, 2021

Adjuvant Treatment for Melanoma in Clinical Practice – Trial vs Reality

European Journal of Cancer


Additional Info

Disclosure statements are available on the authors' profiles:

European Journal of Cancer
Adjuvant treatment for melanoma in clinical practice - Trial versus reality
Eur. J. Cancer 2021 Nov 01;158(xx)234-245, MM de Meza, RK Ismail, D Rauwerdink, OJ van Not, J van Breeschoten, WAM Blokx, A de Boer, M van Dartel, DL Hilarius, E Ellebaek, HJ Bonenkamp, CU Blank, MJB Aarts, ACJ van Akkooi, FWPJ van den Berkmortel, MJ Boers-Sonderen, JWB de Groot, JB Haanen, GAP Hospers, EW Kapiteijn, D Piersma, RS van Rijn, AAM van der Veldt, A Vreugdenhil, HM Westgeest, AJM van den Eertwegh, KPM Suijkerbuijk, MWJM Wouters

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading